Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prewarming Iopamidol for Coronary CTA
NCT05489055Unknown
- Start
- Feb 2022
- Primary completion
- Jan 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of iopamidol. Primary endpoint: Vessel Attenuation at 1 month. Status: unknown.
02
Drugs
iopamidol
Beyond the preview
Go deeper on NCT05489055.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05489055.